A Reason for Hope

Published January 8, 2013

A reason for hope

Filed under: free drug treatment programs

For six months, she was on a new anti-cancer drug, SGN-35, which was approved by the U.S. Food and Drug Administration on Aug. 19, 2011. In trials of … "We plan on having a bigger wedding, a properly planned wedding, once I am cancer-free and all …
Read more on Reading Eagle

Baxter to Initiate Late-Stage Clinical Trial of BAX 855 for the Treatment of …

Filed under: free drug treatment programs

DEERFIELD, Ill.–(BUSINESS WIRE)– Baxter International Inc. (NYS: BAX) today announced it has submitted an Investigational New Drug (IND) application for its investigational hemophilia A treatment BAX 855 with the U.S. Food and Drug Administration …
Read more on DailyFinance

Why Achillion Pharmaceuticals' Shares Soured

Filed under: free drug treatment programs

What: Shares of hepatitis-C-focused biotechnology company Achillion Pharmaceuticals (NASDAQ: ACHN ) dropped as much as 12% following the release of interim results for a phase 2a trial with its lead drug candidate, ACH-3102. So what: The interim …
Read more on Motley Fool